Is Cetrotide in shortage in 2026? Get the latest update on Cetrorelix availability, pricing, new generic options, and how to find it for your IVF cycle.
If you've been told your pharmacy can't get Cetrotide, you're probably wondering: is there an official shortage? Is the drug being discontinued? And most importantly — what does this mean for your IVF cycle?
Let's cut through the confusion and give you a clear picture of where things stand with Cetrotide (Cetrorelix Acetate) in 2026.
As of early 2026, Cetrotide is not listed on the FDA or ASHP drug shortage databases. That means there is no officially recognized shortage of this medication at the federal level.
However, "not in shortage" doesn't always mean "easy to find." Many patients still experience difficulty locating Cetrotide at their pharmacy. Here's why:
For a deeper look at the reasons behind these access issues, read our article on why Cetrotide is so hard to find.
Even without a formal shortage, several factors make Cetrotide challenging to locate:
Cetrotide used to come in two dosage options: a 0.25 mg daily injection and a single 3 mg dose. The 3 mg formulation has been discontinued. This means all patients now use the 0.25 mg daily dose, which requires 5 to 7 injections per IVF cycle. That shift has increased demand for the remaining formulation.
Cetrotide requires special storage and comes as a powder that needs reconstitution. It's not the kind of medication that sits on a CVS shelf next to allergy pills. It flows through specialty pharmacy channels, and not every pharmacy has access to the same wholesaler network.
IVF utilization continues to climb year over year. More patients pursuing fertility treatment means more demand for GnRH antagonists like Cetrotide and Ganirelix. Supply hasn't always kept pace with this growth.
Cost is a real concern, especially for patients paying out of pocket for IVF. Here's what you can expect to pay in 2026:
The availability of multiple generic manufacturers has brought prices down significantly compared to just a few years ago. For a full breakdown of savings strategies, see our guide to saving money on Cetrotide.
One of the biggest positive developments for patients is the expanding availability of generic Cetrorelix Acetate. As of 2026, five manufacturers have FDA approval:
Having five approved generic manufacturers means more supply in the market, more pharmacy availability, and lower prices for patients. If brand-name Cetrotide isn't available, generic Cetrorelix is the same medication at a fraction of the cost.
Here are your best options for locating Cetrotide or Cetrorelix in 2026:
Medfinder lets you search for pharmacies that have Cetrotide or generic Cetrorelix in stock near your location. It's the fastest way to skip the phone-call runaround.
Your IVF clinic likely has relationships with specialty pharmacies that reliably stock fertility medications. Ask your nurse coordinator for recommendations.
If Cetrorelix options are limited, Ganirelix is another GnRH antagonist with identical clinical outcomes. Your doctor can prescribe it as a direct substitute. Learn more in our alternatives guide.
Don't wait until you need the medication to start looking. Fill your prescription as soon as your clinic provides your protocol. For more practical tips, see our guide on how to find Cetrotide in stock near you.
While Cetrotide isn't in an official shortage in 2026, the reality on the ground can still feel like one — especially if you're mid-cycle and can't find it. The good news is that generic Cetrorelix is more available than ever, prices are coming down, and Ganirelix offers a reliable alternative.
Stay proactive: use Medfinder, work with your fertility team, and plan ahead. Your IVF cycle doesn't have to be derailed by a medication access issue.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
